A man with type 1 diabetes has become the first patient to produce his own insulin after receiving genetically engineered cell transplants, without needing drugs to prevent rejection. The case, published this month in the New England Journal of Medicine, marks a potential breakthrough in the treatment of the disease, which affects 9.5 million people worldwide. Type 1 diabetes occurs …
Read More »Diabetes patient produces own insulin after gene-edited cell transplant – without anti-rejection drugs TechSpot First gene-edited islet transplant in a human passes functional trial Medical Xpress Transplanted Islet Cells Survive Without Immune Suppression Medscape Novel T1D Therapy Opens the Door to Cell Transplants Sans Immunosuppressants MedPage Today Diabetic Man With Gene-Edited Cells Produces His Own Insulin—No Transplant Drugs Required Gizmodo Source link
Read More »
A new case study offers a tantalizing glimpse into the potential future of transplantation medicine. A man with type 1 diabetes is now able to make his own insulin thanks to a transplant of gene-edited pancreatic cells—a transplant that hasn’t required the typical drugs used to avoid rejection. Scientists in Sweden and the U.S. conducted the research, published this week …
Read More »